Bob M. Moore II, Ph.D.

Bob M. Moore II, Ph.D.


Department of Pharmaceutical Sciences

The University of Tennessee Health Science Center
874 Union Avenue, Room 327D
Memphis, TN 38163
Tel: (901) 448-6085
Fax: (508) 448-6828
Email: Bob M. Moore


  • B.S. in Chemistry, Indiana State University, 1983
  • M.S. in Chemistry, Indiana State University, 1989
  • Ph.D. (Medicinal Chemistry), University of Kansas, 1995

Research Interests

Research in Dr. Moore's lab integrates synthetic organic chemistry, computational chemistry and biological assays aimed at developing new chemotherapeutic entities. The current areas of research include:

  1. Development of cannabinoid receptor (CB1 and CB2) agonist and antagonist.
  2. Development of novel therapies for combat causality care with emphasis on hemorrhagic shock and hemostasis.
  3. Development of GPRC directed anti-neoplastic agents.
  4. Combination drug therapies for the treatment of sepsis, stroke and ischemic brain conditions.

Representative Publications

  • Moore BM, Sy RW. Cryoballoon Versus Radiofrequency Ablation for Atrial Fibrillation - Is There a Role for Individualised Patient Selection? Heart Lung Circ. 2018 Dec 3. pii: S1443-9506(18)31997-8. doi: 10.1016/j.hlc.2018.11.012. [Epub ahead of print] PubMed PMID: 30528213.
  • Moore BM, Anderson R, Nisbet AM, Kalla M, du Plessis K, d'Udekem Y, Bullock A, Cordina RL, Grigg L, Celermajer DS, Kalman J, McGuire MA. Ablation of Atrial Arrhythmias After the Atriopulmonary Fontan Procedure: Mechanisms of Arrhythmia and Outcomes. JACC Clin Electrophysiol. 2018 Oct;4(10):1338-1346. doi: 10.1016/j.jacep.2018.08.012. PubMed PMID: 30336880.
  • Moore BM, Sy RW, Chan KH. A wobbling tachycardia: What is the mechanism? Heart Rhythm. 2018 Oct;15(10):1583-1584. doi: 10.1016/j.hrthm.2018.06.015. PubMed PMID: 30274619.
  • Wang P, Moore BM, Panchy NL, Meng F, Lehti-Shiu MD, Shiu SH. Factors Influencing Gene Family Size Variation Among Related Species in a Plant Family, Solanaceae. Genome Biol Evol. 2018 Oct 1;10(10):2596-2613. doi: 10.1093/gbe/evy193. PubMed PMID: 30239695; PubMed Central PMCID: PMC6171734.
  • Moore BM, Cordina RL, McGuire MA, Celermajer DS. Adverse effects of amiodarone therapy in adults with congenital heart disease. Congenit Heart Dis. 2018 Sep 21. doi: 10.1111/chd.12657. [Epub ahead of print] PubMed PMID: 30239160.
  • Moore BM, Schellinger K. An Examination of the Moderating Effect of Proactive Coping in NICU Nurses. J Perinat Neonatal Nurs. 2018 Jul/Sep;32(3):275-285. doi: 10.1097/JPN.0000000000000353. PubMed PMID: 30036310.

View more references (pubmed link)